Paul D. Carriere

Amisulpride has a superior benefit/risk profile to haloperidol in schizophrenia: results of a multicentre, double-blind study (the Amisulpride Study Group*

T. Lempérière, D. Bonhomme, P. Carrière, 2000, European Psychiatry.